Epidemiologist | Pfizer UK Ltd | United Kingdom
Dr. Andrew Vyse is a seasoned epidemiologist with extensive experience in both the pharmaceutical industry and public health research. He specializes in vaccine-preventable and potentially vaccine-preventable infections, contributing significantly to the field with over 80 peer-reviewed publications.
Profile
Scopus
Strengths for the Awards
- Prolific Research Contributions:
- Dr. Vyse has authored over 80 peer-reviewed publications, which demonstrates a consistent and significant contribution to epidemiological research, particularly in the area of vaccine-preventable diseases.
- Recent publications cover diverse, critical topics such as Lyme disease, pneumococcal vaccination, RSV, and cost-effectiveness of vaccine strategies. This breadth indicates a comprehensive understanding of the field.
- Impact on Public Health:
- His work in vaccine-preventable diseases directly contributes to public health improvements, including informing vaccination strategies and addressing vaccine-preventable hospitalizations.
- Industry and Academic Experience:
- A balance of pharmaceutical industry experience (Pfizer and GSK) and public health research (UKHSA) highlights his ability to bridge scientific research with practical applications.
- This unique positioning allows him to contribute to both policy-making and the development of new vaccine technologies.
Education 🎓
Dr. Vyse holds a PhD and MSc, reflecting his robust academic foundation in epidemiology and public health. His educational background has equipped him with the expertise to drive impactful research and clinical applications in his field.
Professional Experience 💼
- Feb 2017 – Present: Clinical Epidemiologist at Pfizer UK Ltd, supporting the UK Medical Team and global Scientific Affairs for vaccines including pneumococcal, RSV, COVID, meningococcal, and a candidate Lyme vaccine.
- Jan 2009 – Jan 2017: Global Epidemiologist at GSK Vaccines, contributing to portfolios for meningococcal, DTP, and rotavirus vaccines.
- May 1993 – Dec 2008: Clinical Scientist at the UK Health Security Agency (formerly Public Health England), focusing on surveillance and epidemiological research for vaccine-preventable infections.
Research Interests On Medicine 🧬
Dr. Vyse’s research interests revolve around vaccine-preventable diseases, with a particular focus on respiratory infections, Lyme borreliosis, and strategies to optimize vaccination coverage in vulnerable populations.
Awards and Recognition 🏆
Dr. Vyse has been recognized for his contributions to epidemiology and vaccine research. His work has garnered significant academic and industry accolades, reflecting his impact on public health initiatives and vaccine development.
Publications 🔖
1. Estimating adult accident and emergency attendances in English hospitals attributed to respiratory syncytial virus
- Authors: Vyse, A., Wright, H., Begier, E.
- Year: 2024
- Citations: 0
2. Using Catalytic Models to Interpret Age-Stratified Lyme Borreliosis Seroprevalence Data
- Authors: Vyse, A., Colby, E.
- Year: 2024
- Citations: 0
3. Incidence of symptomatic Lyme borreliosis in nine European countries
- Authors: Angulo, F.J., Colby, E., Lebech, A.-M., Moïsi, J.C., Stark, J.H.
- Year: 2024
- Citations: 1
4. Adult risk groups for vaccine-preventable respiratory infections: an overview of the UK environment
- Authors: Reynard, C., Campling, J., Gordon, A.L., Wright, H., Ellsbury, G.
- Year: 2024
- Citations: 0
5. Estimating the Cost-Effectiveness of Switching to Higher-Valency Pediatric Pneumococcal Conjugate Vaccines in the United Kingdom
- Authors: Wilson, M., Lucas, A., Mendes, D., Ellsbury, G.F., Perdrizet, J.
- Year: 2023
- Citations: 9
6. Assessing the Role of Infant and Toddler MenACWY Immunisation in the UK
- Authors: Schley, K., Kowalik, J.C., Sullivan, S.M., Tichy, E., Findlow, J.
- Year: 2023
- Citations: 0
7. Vaccine-Preventable Hospitalisations from Seasonal Respiratory Diseases: What Is Their True Value?
- Authors: Neri, M., Brassel, S., Schirrmacher, H., Steuten, L., Hamson, E.
- Year: 2023
- Citations: 4
8. A Retrospective Database Study of Lyme Borreliosis Incidence in Poland from 2015 to 2019
- Authors: Paradowska-Stankiewicz, I., Zbrzezniak, J., Skufca, J., Gessner, B.D., Stark, J.H.
- Year: 2023
- Citations: 5
9. Incidence of Lyme Borreliosis in Germany
- Authors: Skufca, J., Tran, T.M.P., Brestrich, G., Gessner, B.D., Stark, J.H.
- Year: 2023
- Citations: 2
10. Incidence of Lyme Borreliosis in the Dutch General Practice Population
- Authors: Houben, E., De Jong, H., Penning-Van Beest, F., Herings, R., Stark, J.H.
- Year: 2023
- Citations: 3
Conclusion 🌐
Dr. Andrew Vyse’s work bridges the pharmaceutical industry and public health research, driving innovations in vaccine development and disease prevention. His dedication to epidemiology continues to advance global health outcomes, underpinned by his extensive research, impactful publications, and commitment to public health initiatives.
